Vixotrigine clinical trials

Studies by the year they started

20 studies that test it; most in 2016 (6)

Who runs them

Industry 20 · Other 0

Biogen (20)

Often tested with

Tested in the same studies.

Valproic Acid (1) · BIIB-095 (1)

Studies

Open first, then newest update. How each study uses vixotrigine is read from its arms, and is right about nine times in ten.

Testing it · 20

• 802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal NeuralgiaWithdrawnPhase 3BiogenNCT03070132Written as BIIB074
• 802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal NeuralgiaWithdrawnPhase 3BiogenNCT03637387Written as BIIB074
• Efficacy and Safety Study of BIIB074 in Participants With Small Fiber NeuropathyTerminatedPhase 2BiogenNCT03339336Written as BIIB074
• Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic PolyneuropathyWithdrawnPhase 1BiogenNCT04106050Written as BIIB074
• Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074TerminatedPhase 2BiogenNCT02957617Written as BIIB074
• A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal NeuralgiaCompletedPhase 2BiogenNCT01540630Written as CNV1014802
• A Drug Interaction Study of BIIB074 and an Oral Contraceptive RegimenCompletedPhase 1BiogenNCT03324685Written as BIIB074
• Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral RadiculopathyCompletedPhase 2BiogenNCT02935608Written as BIIB074
• Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074CompletedPhase 1BiogenNCT03385525Written as BIIB074
• A Phase 2a Study of BIIB074 in the Treatment of ErythromelalgiaCompletedPhase 2BiogenNCT02917187Written as BIIB074
• Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.CompletedPhase 1BiogenNCT00908154Written as GSK1014802
• Effect of GSK1014802 on Electrical Hyperalgesia and Threshold Tracking in Healthy SubjectsTerminatedPhase 1BiogenNCT00964288Written as GSK1014802 low dose
• Study to Investigate the Effect of GSK1014802 on Ambulatory Blood PressureCompletedPhase 1BiogenNCT00955396Written as GSK1014802
• Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy SubjectsCompletedPhase 1BiogenNCT02551497Written as CNV1014802
• Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral RadiculopathyCompletedPhase 2BiogenNCT01561027Written as CNV1014802
• PK & Tolerability of CNV1014802 in Young and Elderly Healthy VolunteersCompletedPhase 1BiogenNCT02359344Written as CNV1014802
• PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian ParticipantsCompletedPhase 1BiogenNCT02831517Written as BIIB074
• New Formulation and Food Effect Study of BIIB074CompletedPhase 1BiogenNCT02951221Written as BIIB074 Treatment A
• Absorption, Metabolism, and Excretion Study of BIIB074CompletedPhase 1BiogenNCT02751905Written as BIIB074
• Effect of Itraconazole on the Pharmacokinetics of BIIB074CompletedPhase 1BiogenNCT02698267Written as BIIB074

Codes

What other systems call vixotrigine · ClinicalTrials.gg INT000081

• MeSH (NLM) C000592131vixotrigineOne source NLM
• UNII (FDA) QQS4J85K6YVIXOTRIGINEConfirmed FDA, NLM, Wikidata
• Wikidata Q18386159vixotrigineConfirmed FDA, NLM, Wikidata
• NCI Thesaurus C152899VixotrigineOne source FDA
• DrugBank DB11706One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.